Evidence map›Paper›PMID 36171028›Full record

ArticleBMJ open2022

Study protocol: use of a smartphone application to support the implementation of a complex physical activity intervention (+

Ralph Smith, Yvonne Kenworthy, Nerys M Astbury, Jacqueline Birks, Paul Bateman, Pamela Dyson, Jane E Hirst, Susan A Jebb, Moscho Michalopoulou, Richard Pulsford and 6 more

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Ralph SmithSport and Exercise Medicine, Rheumatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK ralph.smith@ouh.nhs.uk.ORCID 0000-0003-0738-7626
Yvonne KenworthyOxford Cardiovascular Clinical Research Facility, University of Oxford, Oxford, Oxfordshire, UK.
Nerys M AstburyNuffield Department of Primary Care Health Sciences, Univeristy of Oxford, Oxford, UK.ORCID 0000-0001-9301-7458
Jacqueline BirksCentre for Statistics in Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-8310-9911
Paul BatemanNuffield Department of Primary Care Health Sciences, Univeristy of Oxford, Oxford, UK.
Pamela DysonOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Jane E HirstNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
Susan A JebbNuffield Department of Primary Care Health Sciences, Univeristy of Oxford, Oxford, UK.
Moscho MichalopoulouNuffield Department of Primary Care Health Sciences, Univeristy of Oxford, Oxford, UK.
Richard PulsfordCollege of Life and Environmental Sciences, University of Exeter, Exeter, UK.
Cristian RomanInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, Oxfordshire, UK.
Mauro SantosInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, Oxfordshire, UK.
Lionel TarassenkoInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, Oxfordshire, UK.
Nicola WangoWomen Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
Amy WirePatient representative, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
Lucy H MacKillopNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-1927-1594
University of Oxford · GBOxford University Hospitals NHS Trust · GBUniversity of Exeter · GB

Funding

Medical Research Council MR/T040750/1
6 · The paper itself

Abstract

introductionPhysical activity (PA) interventions have a promising role in the management of gestational diabetes mellitus (GDM). Digital technologies can support PA at scale and remotely. The protocol describes a study designed to determine the feasibility and acceptability of a complex intervention; known as +Stay Active. +Stay Active combines motivational interviewing with a bespoke behaviour change informed smartphone application (Stay-Active) to augment PA levels in women with GDM. METHODS AND ANALYSIS: This is a non-randomised feasibility study using a mixed methods approach. Participants will be recruited from the GDM antenatal clinic at the Women Centre, John Radcliffe Hospital, Oxford. Following baseline assessments (visit 1) including self-reported and device determined PA assessment (wearing a wrist accelerometer), women will be invited to participate in an online motivational interview, then download and use the Stay-Active app (Android or iOS) (visit 2). Women will have access to Stay-Active until 36 weeks gestation, when engagement and PA levels will be reassessed (visit 3). The target sample size is 60 women. Primary outcomes are recruitment and retention rates, compliance and assessment of participant engagement and acceptability with the intervention. Secondary outcomes are assessment of blood glucose control, self-reported and device determined assessment of PA, usage and structured feedback of participant's attitudes to +Stay Active, assessment of health costs and description of maternal and neonatal outcomes. This study will provide key insights into this complex intervention regarding engagement in smartphone technology and the wearing of accelerometers. These data will inform the development of a randomised controlled trial with refinements to intervention implementation. ETHICS AND DISSEMINATION: The study has received a favourable opinion from South Central-Hampshire B Research Ethics Committee; REC reference: 20/SC/0342. Written informed consent will be obtained from all participants. Findings will be disseminated through peer-reviewed journals, conferences and seminar presentations. TRIAL REGISTRATION NUMBER: ISRCTN11366562.

Indexed as

Diabetes, GestationalMobile ApplicationsExerciseFeasibility StudiesFemaleHumansInfant, NewbornPregnancySmartphoneDiabetes in pregnancyInformation technologyMaternal medicinePUBLIC HEALTH

Identifiers

PMID36171028
PMCPMC9528591
OpenAlexW4298087029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.